Monday, October 15, 2001
In granting Tanox Inc. clear rights to one of its two most advanced
proprietary compounds, a U.S. federal court judge last week provided an object lesson to
would-be partners and their lawyers about sloppy contract writing.
Marilyn Hall Patel, chief judge of the U.S. District Court for the
Northern District of California, last week issued a summary judgement in favor of TNOX
(Houston, Texas) in a suit brought by Genentech Inc. (DNA, South San Francisco, Calif.)
and Novartis AG (NVS; SWX:NOVN, Basel, Switzerland).